These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26596811)

  • 41. Greater response to cardiac resynchronization therapy in patients with true complete left bundle branch block: a PREDICT substudy.
    Perrin MJ; Green MS; Redpath CJ; Nery PB; Keren A; Beanlands RS; Birnie DH
    Europace; 2012 May; 14(5):690-5. PubMed ID: 22170897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating strict and conventional left bundle branch block criteria using electrocardiographic simulations.
    Galeotti L; van Dam PM; Loring Z; Chan D; Strauss DG
    Europace; 2013 Dec; 15(12):1816-21. PubMed ID: 23703366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac Resynchronization Therapy in Women.
    Costanzo MR
    Card Electrophysiol Clin; 2015 Dec; 7(4):721-34. PubMed ID: 26596814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Newer Echocardiographic Techniques in Cardiac Resynchronization Therapy.
    Gorcsan J; Tayal B
    Card Electrophysiol Clin; 2015 Dec; 7(4):609-18. PubMed ID: 26596806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac resynchronization therapy: who benefits?
    Chinitz JS; d'Avila A; Goldman M; Reddy V; Dukkipati S
    Ann Glob Health; 2014; 80(1):61-8. PubMed ID: 24751566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Indication for CRT].
    Schlösser M; Stellbrink C
    Herzschrittmacherther Elektrophysiol; 2009 Sep; 20(3):103-8. PubMed ID: 19730926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New strict left bundle branch block criteria reflect left ventricular activation differences.
    Emerek K; Risum N; Hjortshøj S; Riahi S; Rasmussen JG; Bloch Thomsen PE; Graff C; Søgaard P
    J Electrocardiol; 2015; 48(5):758-62. PubMed ID: 26233647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR.
    Zusterzeel R; Curtis JP; Caños DA; Sanders WE; Selzman KA; Piña IL; Spatz ES; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Strauss DG
    J Am Coll Cardiol; 2014 Sep; 64(9):887-94. PubMed ID: 25169173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comment on "Defining left bundle branch block in the era of cardiac resynchronization therapy"].
    Oliveira M
    Rev Port Cardiol; 2011 Oct; 30(10):809-11. PubMed ID: 22118135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transseptal conduction as an important determinant for cardiac resynchronization therapy, as revealed by extensive electrical mapping in the dyssynchronous canine heart.
    Strik M; van Deursen CJ; van Middendorp LB; van Hunnik A; Kuiper M; Auricchio A; Prinzen FW
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):682-9. PubMed ID: 23873141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac Resynchronization Therapy in Women.
    Costanzo MR
    Heart Fail Clin; 2017 Jan; 13(1):165-178. PubMed ID: 27886921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrocardiographic criteria of true left bundle branch block: a simple sign to predict a better clinical and instrumental response to CRT.
    Mascioli G; Padeletti L; Sassone B; Zecchin M; Lucca E; Sacchi S; Boggian G; Tondo AL; Belvito C; Bakhtadze N; Borrelli A; Sinagra G
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):927-34. PubMed ID: 22651702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W
    J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ECG in cardiac resynchronization therapy: influence of left and right ventricular preactivation and relation to acute response.
    Bogaard MD; Hesselink T; Meine M; Loh P; Hauer RN; Cramer MJ; Doevendans PA; Tuinenburg AE
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1237-45. PubMed ID: 22734629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acceleration-dependent left bundle branch block with severe left ventricular dyssynchrony results in acute heart failure: are there more patients who benefit from cardiac resynchronization therapy?
    Zeppenfeld K; Schalij MJ; Bleeker GB; Holman ER; Bax JJ
    J Cardiovasc Electrophysiol; 2006 Jan; 17(1):101-3. PubMed ID: 16426411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Underestimation of duration of ventricular activation by 12-lead ECG compared with direct measurement of activation duration derived from implanted pacemaker leads.
    Duncan AM; Lim E; Mebrate Y; Wong T; Gibson DG
    Int J Cardiol; 2011 Oct; 152(1):35-42. PubMed ID: 20678820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reliability and reproducibility of QRS duration in the selection of candidates for cardiac resynchronization therapy.
    De Guillebon M; Thambo JB; Ploux S; Deplagne A; Sacher F; Jais P; Haissaguerre M; Ritter P; Clementy J; Bordachar P
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):890-2. PubMed ID: 20233266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.
    Sipahi I; Carrigan TP; Rowland DY; Stambler BS; Fang JC
    Arch Intern Med; 2011 Sep; 171(16):1454-62. PubMed ID: 21670335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The value of the 12-lead ECG for evaluation and optimization of cardiac resynchronization therapy in daily clinical practice.
    van Deursen CJ; Blaauw Y; Witjens MI; Debie L; Wecke L; Crijns HJ; Prinzen FW; Vernooy K
    J Electrocardiol; 2014; 47(2):202-11. PubMed ID: 24444866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy.
    Kandala J; Upadhyay GA; Altman RK; Parks KA; Orencole M; Mela T; Kevin Heist E; Singh JP
    Eur Heart J; 2013 Aug; 34(29):2252-62. PubMed ID: 23571836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.